SCHEMBL21163052

SCHEMBL21163052

CC1(C)CC(OC2CCC(OC3CC(C)(C)NC(C)(C)C3)C(OC3CC(C)(C)NC(C)(C)C3)C2)CC(C)(C)N1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.32
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21163045 0.88 GAA (0.35) GAA
SCHEMBL21163396 0.84 GAA (0.37) GAARECQL
SCHEMBL11051607 0.79 GAA (0.41) GAARECQL
SCHEMBL21162834 0.79 GAA (0.34) GAARECQL
SCHEMBL21162845 0.77
SCHEMBL21163524 0.76
SCHEMBL21163543 0.75 GAA (0.34) GAA
SCHEMBL21162848 0.73 GAA (0.33) GAA
SCHEMBL21163538 0.73 GAA (0.31) GAA
SCHEMBL21163575 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10975305-B2 Piperidine derivative, liquid crystal composition, and liquid crystal display element JNC CORPORATION (JP) 2021-04-13 US disclosed
US-20190194542-A1 PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC CORPORATION (JP) 2019-06-27 US disclosed